1. Home
  2. AFMD vs CLPR Comparison

AFMD vs CLPR Comparison

Compare AFMD & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • CLPR
  • Stock Information
  • Founded
  • AFMD 2000
  • CLPR 2015
  • Country
  • AFMD Germany
  • CLPR United States
  • Employees
  • AFMD N/A
  • CLPR N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • CLPR Real Estate Investment Trusts
  • Sector
  • AFMD Health Care
  • CLPR Real Estate
  • Exchange
  • AFMD Nasdaq
  • CLPR Nasdaq
  • Market Cap
  • AFMD 55.6M
  • CLPR 63.5M
  • IPO Year
  • AFMD 2014
  • CLPR 2017
  • Fundamental
  • Price
  • AFMD $3.65
  • CLPR $5.41
  • Analyst Decision
  • AFMD Strong Buy
  • CLPR Sell
  • Analyst Count
  • AFMD 5
  • CLPR 2
  • Target Price
  • AFMD $16.25
  • CLPR N/A
  • AVG Volume (30 Days)
  • AFMD 98.0K
  • CLPR 118.4K
  • Earning Date
  • AFMD 11-14-2024
  • CLPR 10-31-2024
  • Dividend Yield
  • AFMD N/A
  • CLPR 7.02%
  • EPS Growth
  • AFMD N/A
  • CLPR N/A
  • EPS
  • AFMD N/A
  • CLPR N/A
  • Revenue
  • AFMD $7,959,927.00
  • CLPR $145,595,000.00
  • Revenue This Year
  • AFMD N/A
  • CLPR N/A
  • Revenue Next Year
  • AFMD $48.98
  • CLPR N/A
  • P/E Ratio
  • AFMD N/A
  • CLPR N/A
  • Revenue Growth
  • AFMD N/A
  • CLPR 6.78
  • 52 Week Low
  • AFMD $2.92
  • CLPR $3.38
  • 52 Week High
  • AFMD $8.95
  • CLPR $7.12
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 55.19
  • CLPR 41.77
  • Support Level
  • AFMD $3.63
  • CLPR $5.42
  • Resistance Level
  • AFMD $3.98
  • CLPR $6.40
  • Average True Range (ATR)
  • AFMD 0.24
  • CLPR 0.35
  • MACD
  • AFMD 0.04
  • CLPR -0.10
  • Stochastic Oscillator
  • AFMD 55.65
  • CLPR 13.48

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About CLPR Clipper Realty Inc.

Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.

Share on Social Networks: